Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for RDNT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -63.55M
March 31, 2026 -370.97M
December 31, 2025 -113.94M
September 30, 2025 -75.72M
June 30, 2025 -95.06M
March 31, 2025 -56.75M
December 31, 2024 -34.02M
September 30, 2024 -42.58M
June 30, 2024 -77.34M
March 31, 2024 -56.77M
December 31, 2023 -43.53M
September 30, 2023 -46.91M
June 30, 2023 -40.35M
March 31, 2023 -65.56M
December 31, 2022 -123.90M
September 30, 2022 -27.06M
June 30, 2022 -34.42M
March 31, 2022 -61.56M
December 31, 2021 -62.00M
September 30, 2021 -39.85M
June 30, 2021 -32.31M
March 31, 2021 -87.35M
December 31, 2020 -37.96M
September 30, 2020 -20.68M
June 30, 2020 -12.54M
Date Value
March 31, 2020 -55.06M
December 31, 2019 -5.484M
September 30, 2019 -17.14M
June 30, 2019 -41.65M
March 31, 2019 -29.17M
December 31, 2018 -62.51M
September 30, 2018 -20.70M
June 30, 2018 -31.25M
March 31, 2018 -29.85M
December 31, 2017 -13.51M
September 30, 2017 -16.97M
June 30, 2017 -8.50M
March 31, 2017 -33.97M
December 31, 2016 -5.277M
September 30, 2016 -12.83M
June 30, 2016 -19.74M
March 31, 2016 -27.80M
December 31, 2015 -58.15M
September 30, 2015 27.47M
June 30, 2015 -46.50M
March 31, 2015 -19.62M
December 31, 2014 -9.728M
September 30, 2014 -14.41M
June 30, 2014 -11.31M
March 31, 2014 -18.19M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Castle Biosciences, Inc. -15.96M
Lumexa Imaging Holdings, Inc. -13.64M
Quest Diagnostics, Inc. -134.00M
Labcorp Holdings, Inc. -366.20M
OPKO Health, Inc. 15.54M